Delivering the 2.4 Percent: Unlocking UK Pharma R&D Investment through Evidence-Based Policies
![Delivering the 2.4 Percent: Unlocking UK Pharma R&D Investment through Evidence-Based Policies](https://www.ohe.org/wp-content/uploads/2020/06/Simon-Cover-150x150.png)
Optimal innovation balances willingness and ability to pay with the benefits of future R&D. Our wide-ranging programme aims to promote innovation in health care, increase our understanding of its value, and encourage R&D. New models of innovation should streamline development, reduce costs, and speed patient benefit.